Theranos CEO Elizabeth Holmes, once a media darling and now a regulatory target for mismanagement at her billion dollar blood testing business, did an interview with TODAY earlier this week. The appearance, in which Holmes said she was “devastated” by the problems at the company, sparked a lot of conversation. On professional networking site LinkedIn, I couldn’t help but notice how that conversation seemed to split along gender lines.
